Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Wasim Samara (NPI 1275995177)

Field	Value
Entity Type	Individual
Organization	Wasim Samara
Address	5576 N Shiloh Rd
City	Garland
State	TX
ZIP	75044
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 22, 2016

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is $2.3M in total Medicare revenue with no Medicaid billing on file, so operations are effectively single‑payer focused on Medicare rather than split between Medicare and Medicaid. The absence of any Medicaid claims suggests limited or no participation in Medicaid patient care or billing, which is an important consideration for network access and payer mix analyses.

Revenue is highly concentrated: the precomputed top 3 Medicare codes account for 88.6% of this provider’s total Medicare revenue. Those codes are J0178 $1.7M (73.9%), J2777 $205.3K (8.9%), and 67028 $133.6K (5.8%), indicating most dollars flow from a very small set of injection and intravitreal procedure codes.

The coding mix (J0178, J2777, J2778, J9035, 67028 and high volumes of 92134 and 92012) identifies a retina‑focused ophthalmology practice that centers on intravitreal anti‑VEGF and related injections plus diagnostic retinal imaging. High volumes of therapeutic injection codes combined with frequent retinal imaging and intermediate/comprehensive ophthalmology visits point to a clinic workflow built around recurrent injections and same‑day or serial imaging follow‑up.

Commercial and competitive standing varies by code: for J0178 the provider ranks #330 of 3204 nationally (90th percentile; typical, unremarkable volume) which places them above many peers in absolute placement but is described in the source as a typical national volume profile. By contrast J2777 ranks #1272 of 2039 (37th percentile; typical, unremarkable volume), indicating more modest relative activity for that newer anti‑VEGF agent.

Diagnostic imaging and some evaluation services are statistically elevated: 92134 is ranked #792 of 26868 providers nationally (97th percentile; extreme outlier, far above typical national volume), and 92012 ranks #837 of 17177 (95th percentile; notably above typical national volume). Those placements support the interpretation that this practice runs an above‑typical OCT/imaging throughput and higher‑than‑typical intermediate ophthalmology visit volume relative to national peers.

There is evidence of some therapeutic retina procedures beyond injections but at much lower volume: 67028 shows 1.4K claims, $133.6K revenue (5.8% of Medicare revenue), while procedure codes such as 67228 (48 claims, $13K, 0.6%) and 67108 (12 claims, $10.6K, 0.5%) appear infrequently. This mix implies the practice primarily delivers office‑based injection and imaging services and only occasional laser or surgical retina interventions.

Tenure on file shows NPI enumeration 2016-03-22 (~10 years ago), indicating an established billing presence over roughly a decade; that duration supports stable Medicare relationships and likely established referral patterns for retina care. For payers evaluating network coverage or continuity management, this longevity suggests predictable Medicare billing behavior rather than a newly enumerated entrant.

From a payer contracting and utilization management perspective, the practice’s dependence on J0178 for the majority of revenue (73.9% of Medicare revenue) concentrates financial exposure to changes in reimbursement or utilization controls for that single drug/service. Combined with no Medicaid billing on file, these patterns imply any changes to anti‑VEGF coverage policies or prior authorization for intravitreal injections would disproportionately affect the provider’s Medicare revenue stream and should be a focus for risk and negotiation analyses.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,480	$690	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	7,080	$30	$205.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,390	$100	$133.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,300	$30	$68.8K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	760	$70	$50.4K
J2778	Injection, ranibizumab, 0.1 mg	260	$180	$47.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	170	$130	$21.3K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	140	$100	$14.2K
J9035	Injection, bevacizumab, 10 mg	260	$50	$13.6K
67228	In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space…	50	$270	$13K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

Wasim Samara — 3 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	210	610	$690	$694.9K
J2777	13	140	7,470	$30	$479.2K
J2778	6	80	630	$180	$345.3K
67028	13	290	510	$90	$73K
67108	9	60	20	$1,170	$28.1K
92235	7	160	60	$100	$21.3K
92014	182	2,700	100	$80	$21K
99214	6,435	32,500	110	$80	$17.6K
92012	2	1,690	80	$60	$10.9K
J9035	27	130	90	$50	$9.8K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Wasim Samara, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Vidant Medical Group LLC	NC	Multi-Specialty Clinic/Center	$0	$78M
East Carolina University	NC	Internal Medicine Physician	$0	$53.7M
Eastern Radiologists Inc	NC	Diagnostic Radiology Physician	$0	$14.3M
Kettering Independent Medical Group Inc	OH	Orthopaedic Surgery Physician	$0	$8.4M
Shil Patel	VA	Ophthalmology Physician	$6.1M	$0
James Pate	NC	Ophthalmology Physician	$5.2M	$0
Nitin Gupta	NC	Ophthalmology Physician	$4.7M	$0
John Thordsen	NC	Retina Specialist (Ophthalmology) Physician	$3.5M	$0
Rebecca Manning	NC	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Matthew Cole	TN	Ophthalmology Physician	$3.3M	$0

Nearby Providers

Other providers in the same ZIP code as Wasim Samara, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Larry Hayes	TX	Foot & Ankle Surgery Podiatrist	$1.7M	$0
North Garland Surgery Center LLP	TX	Ambulatory Surgical Clinic/Center	$531.5K	$0
Philip Jimenez	TX	Foot Surgery Podiatrist	$265.9K	$0
Dheeraj Reddy	TX	Medical Oncology Physician	$226.2K	$0
Robert Doyle	TX	Podiatrist	$208.3K	$0

Wasim Samara — Billing Profile & Reimbursement Data

Sign up for Wasim Samara — Billing Profile & Reimbursement Data policy alerts

Wasim Samara — Billing Profile & Reimbursement Data

Sign up for Wasim Samara — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References